ISPECIMEN INC (ISPC)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$1.540.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · ISPC
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance recently climbed back into the top half of its industry — confirming the recovery.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -72.1% |
| Our one-year growth estimate | diamond | -60.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 12.1 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and has been missing across recent quarters. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 33 industry peers · Company calendar date is not available
ISPC — CEO transition
Dated 2026-08-31
CEO — Katharyn Field: The CEO transitioned out of the role to an advisory capacity with an immediate external successor appointed, indicating an orderly succession rather than a sudden loss of leadership.
Why it matters: The success of the capital raise can provide needed funds for growth. Weak demand may signal deeper issues.
Supportive ifManagement says there is strong demand for the recent capital raise.
Worry ifThe capital raise does not get enough interest from investors.
Why it matters: Good marketing can help improve visibility. It may also drive revenue growth.
Supportive ifThe marketing efforts from the consulting deal lead to more engagement and revenue growth.
Worry ifThere is no clear improvement in engagement or revenue. This is despite new marketing.
Why it matters: Maintaining compliance is essential for the company to stay listed on Nasdaq.
Worry ifThe company gets a notice. It confirms they follow Nasdaq listing rules.
Less concerning ifThere are more notices about non-compliance. Nasdaq may threaten delisting.
Why it matters: Completing this program is key for better efficiency. It helps the company stay competitive.
Supportive ifThe company says it finished the digital program. It had good operational results.
Worry ifThe program has delays or does not provide the expected benefits.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$375 on $10,000 · ±3.8% | How much price usually moves either way. |
| Bad day | $1,303 loss on $10,000 · 13.0% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,809 loss on $10,000 · 98.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Closing the placement will bring in needed money for operations and marketing. This could boost investor confidence.
Supportive ifThe private placement closes on or before May 11, 2026, as planned.
Worry ifIf the placement does not close on time, it may show problems with investor interest.
Why it matters: The company received a notice about non-compliance. Updates will indicate if they can maintain their listing.
Worry ifiSpecimen has a good update. They confirm they follow Nasdaq listing rules.
Less concerning ifNasdaq sent more notices about not following rules.
Why it matters: New M&A activity could show growth chances and investor trust in ISPC's plan.
Supportive ifThe company announces a new acquisition or partnership. This will strengthen its market position.
Worry ifNo new M&A announcements are made, showing a lack of growth plans.
Why it matters: New marketing efforts may help the company get noticed and increase sales.
Supportive ifThe company shares good results from the new marketing consulting deal.
Worry ifThe company does not see any clear results from the new marketing efforts.
Why it matters: Finishing this program is important. It helps with efficiency and staying competitive.
Supportive ifThe digital transformation program is on track. It is meeting its goals.
Worry ifThere are delays in the digital transformation program. This shows problems with operations.
Why it matters: Approval is needed to issue more shares, which could impact stockholder value and compliance with Nasdaq rules.
Worry ifStockholders approve more shares at the next meeting.
Less concerning ifStockholders reject the plan. This limits the company's ability to raise money.
Why it matters: Approval is needed to maintain Nasdaq listing and could stabilize the stock price. Failure to get approval may lead to delisting.
Worry ifStockholders approve the reverse stock split at the upcoming meeting within 90 days of the offering's close.
Less concerning ifStockholders reject the reverse stock split, risking delisting from Nasdaq.
Why it matters: The offering's completion is crucial for funding working capital and growth. It shows investor confidence.
Supportive ifThe public offering will close on or before August 7, 2026.
Worry ifThe offering does not close by the expected date. This shows possible investor worries.
Why it matters: Buying AI assets could improve iSpecimen's technology and market position. This may help future growth.
Supportive ifThe acquisition leads to new product offerings or partnerships within six months.
Worry ifThe acquisition has no clear effect on products or market position.